Page 4 - Comparative Effectiveness News Today

A randomized, head-to-head trial shows that common medical masks may only be slightly inferior to N95s for preventing infection among healthcare workers treating COVID patients.

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the upcoming presentation of five posters highlighting data from the Companys...

Researchers compared four drugs for type 2 diabetes treatment in a study that began in 2013 and whose results ...

In a large clinical trial that directly compared four drugs commonly used to treat type 2 diabetes, researchers from the University of Minnesota Medical School aided in the discovery that insulin glargine and liraglutide performed best.

President Obama's proposed Institute for Comparative Effectivenesswould mean more government control of private medical decisions. Itis clear from the British experience and other internationalexamples that a comparative effectiveness strategy that relies oncentral planning and coercion would be counterproductive and wouldlead to cost constraints that could worsen patients' medicalconditions and damage the quality of their lives.

The American Heart Association (AHA) Scientific Sessions 2022 in Chicago, and virtually, is set for November 5-7 at McCormick Place. Highly-anticipated clinical trial breakthroughs and discoveries of the year will be offered in both late-breaking scientific sessions and featured science sessions.

New findings may ease lingering doubts about the therapeutic equivalence and safety of extended-interval vs standard dosing of pembrolizumab.

Contrary to their stated intent, the health care reform bills passed by the House and Senate would sub­stantially increase health care spending if either became law. Based on a fundamental misunderstanding of what drives health care spending, these bills exacerbate many of the inefficiencies in the U.S. health care system, particu­larly those that drive spending upward. While an increased prevalence of disease, the third-party payment system, technological change, and waste and fraud are likel...

A pilot study found that delivery of approximately the same dose over just 2.5 weeks, known as hypofractionation, had good short-term toxicity outcomes.

Liraglutide and insulin glargine performed the best out of 4 commonly used medications to maintain blood glucose levels in the recommended range.